BLyS and BLyS receptor expression in non-Hodgkin's lymphoma
Authors:
- Javier BrionesJBJavier Briones
- Ronald LevyRLRonald Levy
- 1 February 2002
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 30 (2) , 135-141
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunityNature Immunology, 2000
- Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell RegulationJournal of Experimental Medicine, 2000
- Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell PopulationJournal of Experimental Medicine, 2000
- Identification of a receptor for BLyS demonstrates a crucial role in humoral immunityNature Immunology, 2000
- Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic miceProceedings of the National Academy of Sciences, 2000
- Micro-environmental factors in the survival of human B-lymphoma cellsCell Death & Differentiation, 2000
- Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal KinaseJournal of Biological Chemistry, 1999
- CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.Journal of Clinical Investigation, 1997
- Serum immunoreactive interleukin‐6 and C‐reactive protein levels in patients with multiple myeloma at diagnosisBritish Journal of Haematology, 1994
- Direct evidence that human follicular dendritic cells (FDC) rescue germinal centre B cells from death by apoptosisClinical and Experimental Immunology, 1993